title: Current drug development for antidepressants and ideas addressing downstream glutamate: the ketamine example.
authors.affiliation: National Institute of Mental Health, Bethesda, Maryland, USA.
authors.forename: William Z
authors.initials: WZ
authors.lastname: Potter
authors.affiliation: National Institute of Mental Health, Bethesda, Maryland, USA.
authors.forename: Linda S
authors.initials: LS
authors.lastname: Brady
mesh_terms: D000818:Animals; D000928:Antidepressive Agents; D003863:Depression / Q000188:drug therapy*; D055808:Drug Discovery / Q000639:trends*; D018698:Glutamic Acid / Q000378:metabolism / Q000627:therapeutic use*; D006801:Humans; D007649:Ketamine / Q000378:metabolism / Q000627:therapeutic use*
chemical_list: D000928:Antidepressive Agents; D018698:Glutamic Acid; D007649:Ketamine